Benefit-risk assessment to support the FDA's decision on vaccines for SARS-CoV-2

被引：0
|
作者：
Yang, Hong [1 ]
机构：
[1] FDA, CBER, OBPV, Silver Spring, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
243
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [21] SARS-CoV-2 Vaccines: Status Report
    Amanat, Fatima
    Krammer, Florian
    IMMUNITY, 2020, 52 (04) : 583 - 589
  • [22] The SARS-CoV-2 vaccines: Retrospective and perspectives
    Epaulard, Olivier
    INFECTIOUS DISEASES NOW, 2022, 52 (08): : S1 - S1
  • [23] The Current Update of Vaccines for SARS-CoV-2
    Hoang Duc Ha
    Nguyen Minh Duc
    Pham Minh Thong
    ELECTRONIC JOURNAL OF GENERAL MEDICINE, 2020, 17 (05):
  • [24] Re: SARS-CoV-2 Vaccines in Development
    Clemens, J. Quentin
    JOURNAL OF UROLOGY, 2021, 206 (01): : 139 - 139
  • [25] Development of vaccines against SARS-CoV-2
    Leon-Lara, Ximena
    Otero-Mendoza, Francisco
    ACTA PEDIATRICA DE MEXICO, 2020, 41 (04): : S23 - S26
  • [26] Immunogenicity of SARS-CoV-2 vaccines in with cancer
    Kakkassery, Helen
    Carpenter, Esme
    Patten, Piers E. M.
    Irshad, Sheeba
    TRENDS IN MOLECULAR MEDICINE, 2022, 28 (12) : 1082 - 1099
  • [27] Immunology of SARS-CoV-2 infections and vaccines
    Schenten, Dominik
    Bhattacharya, Deepta
    ADVANCES IN IMMUNOLOGY, VOL 151, 2021, 151 : 49 - 97
  • [28] Maintaining Safety with SARS-CoV-2 Vaccines
    Rolla, Giovanni
    Brussino, Luisa
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (10):
  • [29] SARS-CoV-2 virus: Vaccines in development
    Huang, Qingrui
    Yan, Jinghua
    FUNDAMENTAL RESEARCH, 2021, 1 (02): : 131 - 138
  • [30] Influenza Virus and SARS-CoV-2 Vaccines
    Sandor, Adam M.
    Sturdivant, Michael S.
    Ting, Jenny P. Y.
    JOURNAL OF IMMUNOLOGY, 2021, 206 (11): : 2509 - 2520
12345